IM8 Gets a $1 Billion Non-Dilutive Facility to Finance Customer Acquisition

General Catalyst's Customer Value Fund is providing up to $1 billion to IM8, the subscription health-drink subsidiary of public company Prenetics. The facility is not a conventional equity round: it can finance as much as 70% of customer-acquisition costs, with General Catalyst receiving a capped share of revenue generated by the financed customers. General Catalyst receives no ownership stake, avoiding dilution for existing shareholders.